ATP-sensitive K+ channels and insulin secretion: Their role in health and disease

Diabetologia

Volumn 42, Issue 8, 1999, Pages 903-919

  Ashcroft, F M ^a   Gribble, F M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; INSULIN; MEGLITINIDE; NATEGLINIDE; POTASSIUM CHANNEL; POTASSIUM ION; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; DIABETES MELLITUS; DRUG BINDING; DRUG BINDING SITE; DRUG MECHANISM; DRUG SPECIFICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN RELEASE; LIGAND BINDING; MEMBRANE PERMEABILITY; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; POTASSIUM CHANNELS; SULFONYLUREA COMPOUNDS;

EID: 0032787462     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051247     Document Type: Review

References (145)

1. Janbon M, Chaptal J, Vedel A, Schaap J (1942) Accidents hypoglycémiques graves par un sulfamidothiodiazol (le VK 57 ou 2254 RP). Montpellier Med 21-22: 441-444
2. Loubatières A, Goldstein L, Metropolitanski J, Schaap J (1942) Etude expérimentale chez le chien des accidents nerveux irréversibles consécutifs a l'hypoglycémic prolongée provoqué par le sulfa-isopropylthiodiazol. 43ème Congrés des Médecins aliénistes et neurologistes de France et des pays de langue française, Montpellier. Massin, Paris, p 415
3. Franke H, Fuchs J (1955) Ein neues antidiabetisches Prinzip. Dtsch Med Wochenschr. 80: 1449-1452
4. Henquin JC (1992) The fiftieth anniversary of hypoglycaemic sulphonylureas. How did the mother compound work? Diabetologia 35: 907-912
5. Dean PM, Mathews EK (1968) Electrical activity in pancreatic islet cells. Nature 219:389-390
6. Henquin JC (1980) Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia 18: 151-160
7. Sturgess NC, Ashford MLJ, Cook DL, Hales CN (1985) The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 31: 474-475
8. Ashcroft FM, Rorsman P (1989) Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol 54: 87-143
9. 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics. Arzneimittelforschung 35: 707-712
10. Ashcroft FM, Ashcroft SJH (1992) The sulphonylurea receptor. Biochim Biophys Acta 1175: 45-59
11. Aguilar-Bryan L, Nichols CG, Wechsler SW et al. (1995) Cloning of the β-cell high-affinity sulphonylurea receptor: a regulator of insulin secretion. Science 268: 423-425
12. KATP: an inward rectifier subunit plus the sulphonylurea receptor. Science 270: 1166-1169
13. Sakura H, Ämmälä C, Smith PA, Gribble FM, Ashcroft FM (1995) Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 377: 338-344
14. Edwards G, Weston AH (1993) The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 33: 597-637
15. + channels in pancreatic β-cells. Nature 311: 271-273
16. + currents in pancreatic β-cells are regulated by intracellular ATP. Pflügers Arch 405: 305-309
17. Niki I, Ashcroft FM, Ashcroft SJH (1989) The dependence on intracellular ATP concentration of ATP-sensitive K-channels and of Na-K-ATPase in intact HIT-T15 β-cells. FEBS Lett 257: 361-364
18. + channel in insulin-secreting cells. J Biol Chem 262: 1530-15344
19. Ashcroft FM, Harrison DE, Ashcroft SJH (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature 312: 446-448
20. Ashcroft SJH, Weerasinghe LCC, Randle PJ (1973) Interelationship of islet metabolism, adenosine triphosphate content and insulin release. Biochem J 132: 223-231
21. Erecinska M, Bryla J, Michalik M, Meglasson MD, Nelson D (1992) Energy metabolism in islets of Langerhans. Biochim Biophys Acta 1101: 273-295
22. Maechler P, Wang H, Wollheim CB (1998) Continuous monitoring of ATP levels in living insulin secreting cells expressing firefly luciferase. FEBS Lett 422: 328-332
23. + channels in rat pancreatic β-cells is modulated by ADP. FEBS Lett 208: 63-66
24. + channels in an insulin-secreting cell line. FEBS Lett 208: 59-62
25. + channel by long chain acyl-CoA. J Biol Chem 271: 10623-10626.
26. Branström R, Leibiger IB, Leibiger B, Corkey BE, Berggren P-O, Larsson O (1998) Long chain coenzyme A esters activate the pore-forming subunit (Kir6.2) of the ATP-regulated potassium channel. J Biol Chem 273: 31395-31400
27. Bränström R, Corkey BE, Berggren P-O, Larsson O (1997) Evidence for a unique long chain acyl-CoA ester binding site on the ATP-regulated potassium channel in mouse pancreatic β-cells. J Biol Chem 272: 17390-17394
28. ATP channel activation by oleoyl-CoA. J Biol Chem 273: 26383-26387
29. ATP channels. Science 282: 1141-1144
30. ATP channels. Science 282: 1139-1141
31. Fan Z, Makielski JC (1997) Anionic phospholipids activate ATP-sensitive potassium channels. J Biol Chem 272: 5388-5395
32. Prentki M, Corkey BE (1996) Are the β-cell signalling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obseity and NIDDM? Diabetes 45: 273-283
33. Prentki M, Tornheim K, Corkey BE (1997) Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 40:[Suppl 2] S32-S41
34. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE (1992) Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267: 5802-5810
35. Trapp S, Tucker SJ, Ashcroft FM (1997) Activation and inhibition of K-ATP currents by guanine nucleotides is mediated by different channel subunits. Proc Natl Acad Sci USA 94: 8872-8877
36. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci USA 95: 7185-7190
37. Gribble FM, Tucker, SJ, Ashcroft FM (1997) The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by MgADP and diazoxide. EMBO J 16: 1145-1152
38. Nichols CG, Shyng SL, Nestorowicz A et al. (1996) Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272: 1785-1787
39. ATP channel activity by diazoxide and MgADP. J Gen Physiol 110: 643-654
40. + channels in cardiac muscle. Nature 305: 147-148
41. Nichols CG, Lederer WJ (1991) Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 261: H1675-H1686
42. Quayle JM, Nelson MT, Standen NB (1997) ATP-sensitive and inwardly-rectifying potassium channels in smooth muscle. Physiol Rev 77: 1165-1232
43. Davis NW, Standen NB, Stanfield PR (1991) ATP-dependent potassium channels of muscle cells: their properties, regulation, and possible functions. J Bioenerg Biomembr 23: 509-35
44. + channels and block neurosecretion. Proc Natl Acad Sci USA 87: 3489-3492
45. + channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein and amyloid β-protien precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci USA 90: 9431-9435
46. + channels in mouse pancreatic β-cells. Br J Pharmacol 98: 957-965
47. Faivre J-F, Findlay I (1989) Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. Biochim Biophys Acta 984: 1-5
48. ATP channels in intact mammalian skeletal muscle fibres. Br J Pharmacol 123: 1103-1110
49. ATP channel subunits. Neuron 18: 827-838
50. + channel. FEBS Lett 409: 232-236
51. ATP channel complex. J Gen Physiol 110: 655-664
52. Inagaki N, Tsuura Y, Namba N et al. (1995) Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 270: 5691-5694
53. + channel. J Biol Chem 271: 24321-24325
54. + channels. Neuron 16: 1011-1017
55. Chutkow WA, Simon MC, Le Beau MM, Burant CF (1996) Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes 45: 1439-1445
56. Gribble FM, Ashfield R, Ämmälä C, Ashcroft FM (1997) Properties of cloned ATP-sensitive K-currents expressed in Xenopus oocytes. J Physiol (Lond) 498.1: 87-98
57. Doupnik CA, Davidson N, Lester HA (1995) The inward rectifier potassium channel family. Curr Opin Cell Biol 5: 268-278
58. Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM (1997) Truncation of Kir6.2 produces ATP-sensitive K-channels in the absence of the sulphonylurea receptor. Nature 387: 179-81
59. + channel by 8-Azido-ATP. J Biol Chem 274: 3931-3933
60. Higgins C (1992) ABC transporters: from microorganisms to man. Ann Rev Cell Biol 8: 67-113
61. Higgins C (1995) The ABC of channel regulation. Cell 82: 693-696
62. Tusnady GE, Gakos E, Varadi A, Sarkadi B (1997) Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett 402: 1-3
63. Raab-Graham KF, Cirilo LJ, Boettcher AA, Radeke CM, Vandenberg CA (1999) Topology of the amino terminal region of the sulphonylurea receptor. Biophys J 76: A328 (Abstract)
64. + channel. J Physiol (Lond) 499.3: 715-720
65. Liss B, Bruns R, Röper J (1999) Alternative sulphonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopamineric midbrain neurones. EMBO J 18: 833-846
66. ATP channel formation by SUR1 receptors with Kir6.2 receptors in dorsal vagal neurones in situ. J Physiol 509: 339-346
67. ATP channels. Neuron 22: 537-548
68. Ashcroft FM, Gribble FM (1998) Correlating structure and function in ATP-sensitive K + channels. Trends Neurosci 21: 288-294
69. ATP channels by the Kir6.2 subunit. J Gen Physiol 110: 141-153
70. + channels linked to the green fluorescent protein in human embryonic kidney cells (HEK 293) J Physiol 510: 333-345
71. ATP channel inhibition by ATP. EMBO J 17: 3290-3296
72. ATP channel gating and implications for channel inhibition by ATP. J Gen Physiol 112: 333-349
73. ATP channel inhibition by ATP requires distinct functional domains of the cytoplasmic C terminus of the pore-forming subunit. Proc Natl Acad Sci USA 95: 13953-13958
74. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci USA 95: 7185-7190
75. Senior AE, Gadsby DC (1997) ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. Seminars in Cancer Biol 8: 143-150
76. + channels in mouse pancreatic β-cells. Proc R Soc Lond B Biol Sci 243: 139-144
77. Hopkins WF, Fatherazi S, Peter-Riesch B, Corkey BE, Cook DL (1992) Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels in mouse pancreatic β-cells and HIT cells. J Memb Biol 129: 287-295
78. Garrino MG, Schmeer W, Nenquin M, Meissner HP, Henquin JC (1985) Mechanism of the stimulation of insulin release in vitro by HB699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia 28: 697-703
79. Schwanstecher C, Meyer M, Schwanstecher M, Panten U (1998) Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of β-cell. Br J Pharmacol 123: 1023-1030
80. Akiyoshi M, Kakei M, Nakazaki M, Tanaka H (1995) A new hypoglycaemic agent, A1466, inhbits ATP-sensitive potassium channels in rat pancreatic β-cells. Am J Physiol 268: E185-E193
81. Gribble FM, Tucker SJ, Ashcroft FM (1997) The interaction of nucleotides with the tolbutamide block of K-ATP currents: a reinterpretation. J Physiol (Lond) 504. 1: 35-45
82. ATP channels. Diabetes 47: 1412-1418
83. Sator G, Melander A, Scherstén B, Wåhlin-Boll E (1980) Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide. Eur J Clin Pharmacol 17: 285-293
84. Sator G, Melander A, Scherstén B, Wåhlin-Boll E (1980) Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 18: 17-22
85. + loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res 69: 623-637
86. ATP channels to gliclazide. Diabetologia 42: 845-848
87. + currents in pancreatic B-cells. Naunyn-Schmiedebergs Arch Pharmacol 337: 225-230
88. + channels in cardiac muscle by the sulphonylurea drug glibenclamlide. J Pharm Exp Ther 261: 540-545
89. Krause E, Englert H, Gogelein H (1995) Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflugers Arch 429, 625-635
90. ++ complex of ATP. J Pharmacol Exp Ther 262: 495-502
91. Rufer C, Losert W (1974) Blood glucose lowering sulfonamides with asymetric carbon atoms. Related N-substituted carbamoylbenzoic acids. J Med Chem 22, 750-752
92. Garrino M-G, Meissner H-P, Henquin J-C (1986) The non-sulfonylurea moiety of gliquidone mimics the effects of the parent molecule on pancreatic B-cells. Eur J Pharmacol. 124: 309-316
93. + channels from pancreatic β-cells. FEBS Lett 239: 241-244
94. Schwanstecher C, Dickel C, Panten U (1992) Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K-channel in mouse pancreatic β-cells by their combined actions at inhibitory and stimulatory sites. Mol Pharmacol. 41: 480-486
95. Ueda K, Komine J, Matsuo M, Seino S, Amachi T (1999) Cooperative binding of ATP and MgADP in the sulphonylurea receptor is modulated by glibenclamide. Proc Natl Acad Sci USA 96: 1268-1272
96. ATP channels by glibenclamide in rat ventricular myocytes. J Cardiovasc Electrophysiol 4: 38-47
97. +-channel in pancreatic β-cells. Pflügers Arch 407: 493-499
98. Sturgess NC, Kozolowski RZ, Carrington CA, Hales CN, Ashford MLJ (1988) Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br J Pharmacol 95: 83-84
99. Zünckler BJ, Trube G, Panten U (1989) How do sulphonylureas approach their receptor in the B-cell plasma membrane? Naunyn-Schmiedebergs Arch Pharmacol 340: 328-332
100. Lee K, Ozanne SE, Rowe ICM, Hales CN, Ashford MLJ (1994) The effects on trypsin of ATP-regulated potassium channel properties and sulphonylurea receptors in the CRI-G1 insulin secreting cell line. Mol Pharmacol 45: 176-185
101. Schwanstecher M, Schwanstecher C, Dickel C, Chudzaik F, Moshiri A, Panten U (1994) Location of the sulphonylurea receptor at the cytoplasmic face of the β-cell membrane. Br J Pharmacol 113: 903-911
102. Ashfield R, Gribble FM, Ashcroft SJH, Ashcroft FM (1999) Identification of the high-affinity tolbutamide site on the SUR1 subunit of the KATP channel. Diabetes 48: 1341-1347
103. Ämmälä C, Moorhouse A, Gribble F et al. (1996) Promiscuous coupling between the sulphonylurea receptor and inwardly-rectifying potassium channels. Nature 379, 545-548
104. Virsolvy A, Brück M, Dufour M, Cauvin A, Lupo B, Bataille D (1988) An endogenous ligand for the sulphonylurea receptor. FEBS Lett 242: 65-69
105. ATP channel regulator. Proc Natl Acad Sci USA 95: 8387-8391
106. Girault JA, Horiuchi A, Gustafson E, Rosen N, Greengard P (1990) Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions. J Neurosci 10: 1124-1133
107. Horiuchi A, Williams K, Kurihara T, Nairn A, Greengard P (1990) Purification and cDNA cloning of ARPP-16, a cAMP-regulated phosphoprotein enriched in basal ganglia, and of a related phosphoprotein, ARPP-19. J Biol Chem 265: 9476-9484
108. Smits P, Thien T (1995) Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM? Diabetologia 38: 116-122
109. Leibowitz G, Cerasi E (1996) Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 39: 503-515
110. UKPDS (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type II diabetes (UKPDS 33) Lancet 352: 837-853
111. Groop LC (1992) Sulphonylureas in NIDDM. Diabetes Care 15: 737-754
112. Garlid KD (1996) Cation transport in mitochondria - the potassium cycle. Biochim Biophys Acta 1275: 123-126
113. + conductance in pancreatic zymogen granules:block by glyburide and activation by diazoxide. J Memb Biol 129: 253-266
114. Ozanne SE, Guest PC, Huton JC, Hales CN (1995) Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells. Diabetologia 38: 277-282
115. ATP are on MitoSUR. Biophy J 76: A328
116. Braun M, Anderie I, Thévenod F (1997) Evidence for a 65 kDa sulfonylurea receptor in rat pancreatic zymogen granule membranes. FEBS Lett 411: 255-259
117. Eliasson L, Renström E, Ämmälä C, Deeney JT, Flatt PR, Gabel J, Gromada J, Larsson O, Linstrom P, Rhodes C, Rorsman P (1996) PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β-cells. Science 271: 813-815
118. 2+ in beta-cells. Diabetes 47: 365-373
119. Monge L, Mojena M, Ortega JL, Samper B, Cabello MA, Feliu-JE (1986) Chlorpropamide raises fructose-2,6 bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes 35: 89-96
120. Wang PH, Moller D, Flier JS, Nayak RC, Smith RJ (1989) Coordinate regulation of glucose transporter function, number and gene expression by insulin and sulphonylureas in L6 rat skeletal msucle cells. J Clin Invest 84: 62-67
121. Martz A, Jo I, Jung CY (1989) Sulfonylurea binding to adipocyte membranes and potentiation of insulin-stimulated hexose transport. J Biol Chem 264: 13672-13678
122. Wittenbach VA, Koeppe MK, Lichtner FT, Zimmerman WT, Reiser RW (1994) Basis of selectivity of triflusulfuron methyl in sugar-beets (Beta-vulgaris) Pesticid Biochem Physiol 49: 72-81
123. Thomas PM, Cote GJ, Hallman DM, Mathew PM (1995) Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet 56: 416-421
124. Thomas PM, Cote GJ, Wohllk N et al. (1995) Mutations in the sulphonylurea receptor gene in familial persistent hyperinsulinaemic hypoglycaemia of infancy. Science 268: 425-429
125. Thomas P, Ye Y, Lightner E (1996) Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 5: 1809-1812
126. Nestorowicz A, Wilson BA, Schoor KP et al. (1996) Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Human Mol Genet 5: 1813-1822
127. Otonkoski T, Ämmälä, C, Huopio H et al. (1998) A point mutation inactivating the sulfonylurea receptor is found in the majority of patients with persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 48: 408-415
128. Shyng SL, Ferrigni T, Sheppard JB et al. (1998) Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinaemic hypoglycaemia of infancy. Diabetes 47: 1145-1151
129. ATP channels in pancreatic β-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nature Med 2: 1344-1347
130. ATP channel-deficient mice. Proc Natl Acad Sci USA 95: 10402-10406
131. + channel and linkage studies in Japanese patients. Diabetes 46: 267-269
132. Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM (1996) Sequence variations in the human Kir6.2 gene, a subunit of the β-cell ATP-sensitive K-channel: no association with non-insulin dependent diabetes in white Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia 39: 1233-1237
133. Hani EH, Clement K, Velho G et al. (1997) Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes 46: 688-694
134. + channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes 46: 502-507
135. Padrini R, Bova S, Cargnelli G, Piovan D, Ferrari M (1992) Effects of pinacidil on guinea-pig isolated perfused heart with particular reference to the proarrhythmic effect. Br J Pharmacol 105: 715-719
136. Stoffel M, Patel P, Lo YM et al. (1992) Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet 2: 153-6
137. Vionnet N, Stoffel M, Takeda J et al. (1992) Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356: 721-722
138. Randle PJ (1993) Glucokinase and candidate gene for Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 269-275
139. Froguel P, Vaxillaire M, Sun F et al. (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356: 162-164
140. Terauchi Y, Sakura H, Yasuda K et al. (1995) Analysis of the pancreatic β-cell in the mouse with targeted disruption of the pancreatic beta-cell-specific glucokinase gene. J Biol Chem 270: 30253-30256
141. Sakura H, Ashcroft SJH, Terauchi Y, Kadowaki T, Ashcroft FM (1998) Glucose modulation of ATP-sensitive K-currents in wild-type, homozygous and heterozygous glucokinase knock-out mice. Diabetologia 41: 654-659
142. Maasen JA, Kadowaki T (1996) Maternally inherited diabetes and deafness:a new diabetes subtype. Diabetologia 39: 375-382
143. + channels from human right atrial cardiac myocytes. Pharmacol Toxicol 80: 69-75
144. Panten U, Burgfeld J, Goerke F et al. (1989) Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol 38: 1217-1229
145. + channel. J Physiol 512: 395-406